About Manus Bio
Manus Bio is a company based in Cambridge (United States) founded in 2011 by Gregory Stephanopoulos and Ajikumar Parayil.. Manus Bio has raised $115.93 million across 17 funding rounds from investors including Gates Foundation, BBGI and SBIR. Manus Bio offers products and services including Scale-up Platform, BioStevia, Nootkatone, and Valencene. Manus Bio operates in a competitive market with competitors including Evonik, Kallyope, Proklean Technologies, Calyxia and Mint Innovation, among others.
- Headquarter Cambridge, United States
- Founders Gregory Stephanopoulos, Ajikumar Parayil
-
Sectors
Chemicals & MaterialsHealthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Manus Bio Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$115.93 M (USD)
in 17 rounds
-
Latest Funding Round
$21.23 M (USD), Series B
May 31, 2023
-
Investors
Gates Foundation
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Manus Bio
Manus Bio offers a comprehensive portfolio of products and services, including Scale-up Platform, BioStevia, Nootkatone, and Valencene. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for engineering and scaling bioalternatives sustainably.
Sustainable stevia alternative for better-tasting natural sweeteners.
Flavor compound produced via biomanufacturing for cost-effective use.
Sustainable flavor ingredient derived from microbial cell factories.
Unlock access to complete
Funding Insights of Manus Bio
Manus Bio has successfully raised a total of $115.93M across 17 strategic funding rounds. The most recent funding activity was a Series B round of $21.23 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 17
- Last Round Series B — $21.2M
-
First Round
First Round
(01 Jan 2012)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Series B - Manus Bio | Valuation |
investors |
|
| Sep, 2022 | Amount | Grant - Manus Bio | Valuation |
investors |
|
| Nov, 2020 | Amount | Series B - Manus Bio | Valuation | BBGI |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Manus Bio
Manus Bio has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Gates Foundation, BBGI and SBIR. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed & early stage tech-focused VC investment company funding companies in the US
|
Founded Year | Domain | Location | |
|
Venture capital fund backed by the US Government
|
Founded Year | Domain | Location | |
|
Charitable foundation investments on poverty reduction and healthcare
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Manus Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Manus Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Manus Bio Comparisons
Competitors of Manus Bio
Manus Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evonik, Kallyope, Proklean Technologies, Calyxia and Mint Innovation, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Green specialty chemicals are developed and supplied for multiple industries.
|
|
| domain | founded_year | HQ Location |
The gut-brain axis is explored for therapeutic and nutritional innovations.
|
|
| domain | founded_year | HQ Location |
Probiotic-based cleaning agents are manufactured for industrial use.
|
|
| domain | founded_year | HQ Location |
Green chemicals are developed using microcapsule technology for sustainability.
|
|
| domain | founded_year | HQ Location |
Provider of clean technology for critical metal recovery from e-waste
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Manus Bio
Frequently Asked Questions about Manus Bio
When was Manus Bio founded?
Manus Bio was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Where is Manus Bio located?
Manus Bio is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Who is the current CEO of Manus Bio?
Ajikumar Parayil is the current CEO of Manus Bio. They have also founded this company.
Is Manus Bio a funded company?
Manus Bio is a funded company, having raised a total of $115.93M across 17 funding rounds to date. The company's 1st funding round was a Series B of $75M, raised on Jan 01, 2012.
What does Manus Bio do?
Manus Bio was founded in 2011 in Cambridge, United States, within the biotechnology sector. Phytochemicals are produced through microbial fermentation, where natural processes are recreated in microorganisms. Carbon and plant-derived substrates are converted into ingredients for flavors, fragrances, food, cosmetics, vitamins, pharmaceuticals, and agricultural chemicals. Operations focus on sustainable products derived from natural resources.
Who are the top competitors of Manus Bio?
Manus Bio's top competitors include Kallyope, Mint Innovation and Calyxia.
What products or services does Manus Bio offer?
Manus Bio offers Scale-up Platform, BioStevia, Nootkatone, and Valencene.
Who are Manus Bio's investors?
Manus Bio has 6 investors. Key investors include Gates Foundation, BBGI, SBIR, National Science Foundation, and Nelstone Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.